Sitz KV - Search Results

1

Varicella immunity: persistent serologic non-response to immunization.

Katial RK, Ratto-Kim S, Sitz KV, Moriarity R, Engler RJ. Katial RK, et al. Among authors: sitz kv. Ann Allergy Asthma Immunol. 1999 May;82(5):431-4. doi: 10.1016/S1081-1206(10)62716-0. Ann Allergy Asthma Immunol. 1999. PMID: 10353572

2

Lymphocyte proliferation assay.

Sitz KV, Birx DL. Sitz KV, et al. Methods Mol Med. 1999;17:343-53. doi: 10.1385/0-89603-369-4:343. Methods Mol Med. 1999. PMID: 21380686

3

Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.

Artenstein AW, VanCott TC, Sitz KV, Robb ML, Wagner KF, Veit SC, Rogers AF, Garner RP, Byron JW, Burnett PR, Birx DL. Artenstein AW, et al. Among authors: sitz kv. J Infect Dis. 1997 Feb;175(2):265-71. doi: 10.1093/infdis/175.2.265. J Infect Dis. 1997. PMID: 9203646

4

Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1.

Kim JH, Loveland JE, Sitz KV, Ratto Kim S, Mclinden RJ, Tencer K, Davis K, Burke DS, Boswell RN, Redfield RR, Birx DL. Kim JH, et al. Among authors: sitz kv. Clin Exp Immunol. 1997 May;108(2):243-50. doi: 10.1046/j.1365-2249.1997.d01-1006.x. Clin Exp Immunol. 1997. PMID: 9158092 Free PMC article. Clinical Trial.

5

Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4+ T lymphocyte lines from HIV-1-seropositive patients.

Ratto S, Sitz KV, Scherer AM, Manca F, Loomis LD, Cox JH, Redfield RR, Birx DL. Ratto S, et al. Among authors: sitz kv. J Infect Dis. 1995 Jun;171(6):1420-30. doi: 10.1093/infdis/171.6.1420. J Infect Dis. 1995. PMID: 7769275 Clinical Trial.

6

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Birx DL, Loomis-Price LD, Aronson N, Brundage J, Davis C, Deyton L, Garner R, Gordin F, Henry D, Holloway W, Kerkering T, Luskin-Hawk R, McNeil J, Michael N, Foster Pierce P, Poretz D, Ratto-Kim S, Renzullo P, Ruiz N, Sitz K, Smith G, Tacket C, Thompson M, Tramont E, Yangco B, Yarrish R, Redfield RR. Birx DL, et al. J Infect Dis. 2000 Mar;181(3):881-9. doi: 10.1086/315308. J Infect Dis. 2000. PMID: 10720508 Clinical Trial.

7

Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.

Sitz KV, Loomis-Price LD, Ratto-Kim S, Kenner JR, Sau P, Eckels KH, Redfield RR, Birx DL. Sitz KV, et al. J Infect Dis. 1997 Oct;176(4):1085-9. doi: 10.1086/516517. J Infect Dis. 1997. PMID: 9333173

8

Suspected insulin anaphylaxis and literature review.

Scheer BG, Sitz KV. Scheer BG, et al. Among authors: sitz kv. J Ark Med Soc. 2001 Mar;97(9):311-3. J Ark Med Soc. 2001. PMID: 11233502 Review.

9

Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cells.

Kim JH, Ratto S, Sitz KV, Mosca JD, McLinden RJ, Tencer KL, Vahey MT, St Louis D, Birx DL, Redfield RR. Kim JH, et al. Among authors: sitz kv. Hum Gene Ther. 1994 Dec;5(12):1457-66. doi: 10.1089/hum.1994.5.12-1457. Hum Gene Ther. 1994. PMID: 7711138

10

CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.

Ratto S, Sitz KV, Scherer AM, Loomis LD, Cox JH, Redfield RR, Birx DL. Ratto S, et al. Among authors: sitz kv. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):128-36. doi: 10.1097/00042560-199602010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8556394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results